Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Anne Vanlent currently holds 30,000 shares of Trevi Therapeutics, Inc. (TRVI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anne Vanlent has been a net buyer of TRVI stock. They have purchased $262.1K and sold $257.2K worth of shares.
Anne Vanlent's most recent insider trade was on Jun 13, 2024, when they sold 30,000 shares at $0.00 per share.
Anne Vanlent serves as Executive at Trevi Therapeutics, Inc. (TRVI). They have executed 34 insider transactions totaling $519.4K over their tenure at the company.
Anne Vanlent holds the position of Executive at Trevi Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Anne Vanlent has shown a buying trading pattern, with $262.1K in total purchases and $257.2K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Anne Vanlent was on Jan 13, 2011, when they sold $250.3K worth of IART shares. This transaction involved 5,270 shares at $47.49 per share.
Anne Vanlent currently owns 30,000 shares of Trevi Therapeutics, Inc. (TRVI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Anne Vanlent's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Anne Vanlent has 34 Form 4 filings on record as an insider at Trevi Therapeutics, Inc..
Set alerts for Anne Vanlent and 40,000+ other insiders.